Galen Rask

4PUBLICATIONS
13CO-AUTHORS
Sequence analysisMolecular targetsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 25, 2025
Seclidemstat (SP-2577) Induces Transcriptomic Reprogramming and Cytotoxicity in Multiple Fusion-Positive Sarcomas.

Galen C Rask, Cenny Taslim, Ariunaa Bayanjargal

|Jul 16, 2025
N'-(1-phenylethylidene)-benzohydrazide cytotoxicity is LSD1 independent and linked to Fe-S cluster disruption in Ewing sarcoma.

John W Sherman, Galen C Rask, Bingcong Xiong

|Jun 03, 2024
Seclidemstat blocks the transcriptional function of multiple FET-fusion oncoproteins.

Galen C Rask, Cenny Taslim, Ariunaa Bayanjargal

Pageof 1